Mallinckrodt Pharmaceuticals
MNK
#10436
Rank
C$6.17 M
Marketcap
C$0.46
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

EPS for Mallinckrodt Pharmaceuticals (MNK)

EPS in 2023 (TTM): C-$162.88

According to Mallinckrodt Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is C-$165.44. In 2021 the company made an earnings per share (EPS) of C-$11.57 an increase over its 2020 EPS that were of C-$15.29.

EPS history for Mallinckrodt Pharmaceuticals from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)C-$162.88
2021C-$11.57-24.31%
2020C-$15.29-5.41%
2019C-$16.16-72.67%
2018C-$59.15-291.46%
2017C$30.89797.22%
2016C$3.44-34.03%
2015C$5.22-207.61%
2014C-$4.85-366.73%
2013C$1.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$14.26-108.62%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
C$10.33-106.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$0.86-100.52%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel